NIRS in Neonatal Cardiac Surgery
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Due to the small size of infants and the use of bypass machines, physicians have difficulty assessing whether the infant's brain and body is getting enough oxygen during heart surgery. This study compares continuous monitoring via the NIRS (Near Infrared Spectroscopy) to the traditional methods of determining oxygen saturation.
| Condition |
|---|
|
Hypoplastic Left Heart Surgery |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Prospective |
| Official Title: | Near Infrared Spectroscopy Monitoring of Cerebral Oxygen Saturation in Neonatal Cardiac Surgery - Comparison With Common Methods of Estimating Adequate Systemic Perfusion |
| Enrollment: | 25 |
| Study Start Date: | August 2002 |
| Study Completion Date: | August 2008 |
| Primary Completion Date: | August 2008 (Final data collection date for primary outcome measure) |
One of the limiting factors in treating infants undergoing cardiac surgery is the difficulty in assessing systemic perfusion with accuracy. At Children's Healthcare of Atlanta, Near-infrared Spectroscopy (NIRS) is available, but has never been studied. In patients undergoing first stage palliation (Norwood) for hypoplastic left heart, routine management will be utilized in addition to the NIRS monitor. The following will be documented pre- and post-bypass, then every 4 hours for 24 hours after admission to the Cardiac Intensive Care Unit:NIRS readings, Lactic acid levels,mixed venous saturations,hemoglobin, hematocrit, arterial blood gases, heart rate, blood pressure, central venous pressure, left atrium pressure,core temperature, toe temperature, pulse oximeter reading, urine output, ventilator settings, inotropic levels. All the data will be entered into a database and analyzed.
Eligibility| Ages Eligible for Study: | up to 1 Year |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Neonates with Hypoplastic Left Heart Syndrome undergoing stage 1 palliation with the Norwood procedure.
Inclusion Criteria:
- hypoplastic left heart
- requiring stage 1 palliation
- informed consent obtained
Exclusion Criteria:
- does not have hypoplastic left heart
- is not having stage 1 palliation
- no informed consent
Contacts and Locations
More Information
Publications:
| Responsible Party: | Steven R Tosone MD, Assistant Professor, Emory University |
| ClinicalTrials.gov Identifier: | NCT00166101 History of Changes |
| Other Study ID Numbers: | 459-2002 |
| Study First Received: | September 12, 2005 |
| Last Updated: | November 9, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Emory University:
|
pediatric cardiac surgery |
Additional relevant MeSH terms:
|
Hypoplastic Left Heart Syndrome Heart Defects, Congenital Cardiovascular Abnormalities |
Cardiovascular Diseases Heart Diseases Congenital Abnormalities |
ClinicalTrials.gov processed this record on May 16, 2013